Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 22, 2016 05:30 ET | Source: Genetic Technologies

Genetic Technologies and Verizon IndyCar Series Driver Pippa Mann Update BREVAGenplus(R) Marketing Partnership

MELBOURNE, AUSTRALIA--(Marketwired - Jun 22, 2016) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company specializing in women's health, and provider...
June 21, 2016 05:30 ET | Source: Genetic Technologies

Genetic Technologies Announces Appointment of Senior Medical Director

MELBOURNE, AUSTRALIA--(Marketwired - Jun 21, 2016) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company specializing in women's health, and provider...
May 04, 2016 05:30 ET | Source: Genetic Technologies

Genetic Technologies and Verizon IndyCar Series Driver Pippa Mann to Ring Nasdaq Stock Market Closing Bell on May 6th, 2016

MELBOURNE, AUSTRALIA--(Marketwired - May 4, 2016) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company specializing in women's health, and provider...
March 30, 2016 18:17 ET | Source: Opthea

Opthea Completes Patient Enrolment for OPT-302 Phase 1 Dose Escalation Trial in Patients With Wet AMD

MELBOURNE, AUSTRALIA--(Marketwired - Mar 30, 2016) - Phase 1 trial fully enrolled with 20 patients accrued into 4 planned treatment cohorts of 5 patients each ...
February 22, 2016 05:30 ET | Source: Genetic Technologies

Genetic Technologies and IndyCar's Pippa Mann Announce Partnership to Promote BREVAGenplus(R)

MELBOURNE, AUSTRALIA--(Marketwired - Feb 22, 2016) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company specialising in women's health, is pleased...
December 21, 2015 05:30 ET | Source: Genetic Technologies

Genetic Technologies Announces Publication of Key Scientific Validation Results in Support of BREVAGenplus(R)

MELBOURNE, AUSTRALIA--(Marketwired - Dec 21, 2015) - Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company") announced today the publication of a new...
October 30, 2015 05:30 ET | Source: ARMO BioSciences

ARMO BioSciences Presents Positive Phase 1 Trial Results of AM0010 at Upcoming Medical Conferences

REDWOOD CITY, CA--(Marketwired - Oct 30, 2015) - ARMO BioSciences, Inc., a leading developer of immuno-oncology therapeutics, today announced that positive results from an ongoing Phase 1 clinical...
October 16, 2015 05:30 ET | Source: ARMO Biosciences

Open Monoclonal Technology and ARMO BioSciences Announce Anti-PD1 Antibody and OmniAb(TM) Platform License Agreement

REDWOOD CITY, CA and PALO ALTO, CA--(Marketwired - Oct 16, 2015) - ARMO BioSciences, Inc. (ARMO), a leading developer of immuno-oncology therapeutics and Open Monoclonal Technology, Inc. (OMT),...
August 06, 2015 05:30 ET | Source: Genetic Technologies

Genetic Technologies Granted Key Patents by US Patent Office for BREVAGenplus(R)

MELBOURNE, AUSTRALIA--(Marketwired - Aug 6, 2015) - Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), is pleased to announce the issuance of US...
July 14, 2015 05:30 ET | Source: Genetic Technologies

Genetic Technologies Announces Scientific Validation, Clinical Trial and Peer Review Publication Initiatives

MELBOURNE, AUSTRALIA--(Marketwired - Jul 14, 2015) - Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), is pleased to announce that underpinned by a...